Draft. Pending scientific and legal review. Not medical advice.
Nutrigenomics: genetic variants and nutrition
Nutrigenomics studies genetic variants related to nutrient response, body weight and food intolerances. It may help guide personalised nutrition plans with a professional. Alone it is not a dietary recommendation. The panel GLP-1 block is pharmacogenetics of a prescription medicine.
What the study includes
The catalogue nutrigenomics panel is organised in blocks: macronutrients, micronutrients, body weight, bioactive compounds and food intolerances. It also includes a GLP-1 pharmacogenetics block, which is not a nutrition recommendation but information about a prescription medicine.
Genetic variants are only one factor influencing diet response. Results should be interpreted with the clinical history, habits and personal context.
Prudent use
The information may support a healthcare professional or a nutrition specialist. It does not replace clinical assessment and does not justify drastic diet changes without supervision when disease is present.
No products, supplements or commercial plans are promoted here. This page names the study type available in the catalogue.
Relation to pharmacogenomics and cardiometabolism
The GLP-1 block connects with the pharmacogenomic logic described in the pharmacogenomics area and in resources such as PharmGKB or CPIC, when applicable guidelines exist. Weight and metabolism axes also relate to cardiometabolic panels in the catalogue.
Pending Phase 0: sample, turnaround and panel sensitivity.
